May 29 - June 2, 2026 | Chicago, IL
Veristat is pleased to attend the ASCO Annual Meeting, where oncology leaders, researchers, and clinicians gather to share the latest advances shaping cancer care. As new therapies move through development, the bar for clinical evidence continues to rise, and the path to approval demands both scientific depth and regulatory precision.
We’re looking forward to connecting with sponsors and oncology innovators to exchange perspectives on how programs are evolving in this environment. Veristat supports these efforts with integrated expertise across regulatory, clinical development, and biostatistics, helping teams translate complex data into decisions that hold up under scrutiny and keep development capital working efficiently.
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Full-Service Clinical Development Solutions
Clinical Operations Excellence
Global Regulatory Strategy & Submissions
If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.